Isotopia Molecular Imaging Ltd. to Showcase Innovation in Targeted Radiopharmaceuticals at the TRP Summit

This pivotal event brings together the brightest minds and most forward-thinking companies in the field of radiopharmaceuticals to advance the future of targeted therapies.

Representing Isotopia at this year’s TRP Summit will be Mr. Eyal Gimshi, General Manager of Theranostics, who will share insights on our three-site strategy for a secure global supply of Lutetium-177 and Terbium-161.

Join Isotopia at the TRP Summit to learn more about our role in transforming targeted radiotherapy and enhancing the standard of care for patients worldwide.